Companies Dominating the Vaccine Adjuvants Landscape
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- GSK plc
- SK Bioscience
- Sanofi
- Abbott
- Phibro Animal Health Corporation
- Astrazeneca
- Novavax, Inc.
- Agenus Inc.
- Astellas Pharma Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Vaccine Adjuvants Market in 2025 is estimated at USD 2.29 billion.
The global market size was valued at over USD 2.2 billion in 2024 and is expected to expand at a CAGR of around 5%, surpassing USD 4.15 billion revenue by 2037.
North America is poised to exceed USD 1.45 billion by 2037, attributed to large population of elderly individuals and increasing prevalence of chronic diseases.
The major players in the market include Pfizer Inc., GSK plc, SK Bioscience, Sanofi, Abbott, Phibro Animal Health Corporation, Astrazeneca, Novavax, Inc., Agenus Inc., Astellas Pharma Inc.
